Do patients experience statistically and/or clinically significant improvement in disability scores following three injections

Patient-reported Outcomes of Short-term Intra-articular Hyaluronic Acid for Osteoarthritis of the Knee A Consecutive Case Series.

Article specifications

This clinical trial was published in 2019 in Journal of Cureus. by American specialists. A total of 32 patients with a mean age of 66±14 years receiving Supartz FX were reviewed in a prospective, observational study.

 

Results

Despite manufacturer recommendations, short-term use of Supartz FX for knee osteoarthritis does not meet clinically significant thresholds as the treatment effects for WOMAC sub scores fail to satisfy published MCII criteria.